Blue Ridge Cancer Care — Salem, Virginia

Blue Ridge Cancer Care is a clinical research site located in Salem, Virginia, United States 24153.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Blue Ridge Cancer Care has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: KRAS p.G12C Mutant Advanced Solid Tumors, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer.

Sponsors: Amgen, Pfizer, Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Blue Ridge Cancer Care?

Blue Ridge Cancer Care has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Blue Ridge Cancer Care conducted?

Blue Ridge Cancer Care has 5 clinical trials on record, with 4 currently active. Their work covers KRAS p.G12C Mutant Advanced Solid Tumors, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer.

Is Blue Ridge Cancer Care accredited by Crixeo Health?

Yes — Blue Ridge Cancer Care holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Blue Ridge Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.